Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Aceso Life Science Group Limited ( (HK:0474) ) has shared an announcement.
Aceso Life Science Group Limited has entered into a conditional subscription agreement with IFGL under which Aceso will subscribe for 2,624 new shares in IFGL, representing about 24.59% of IFGL’s existing share capital and roughly 19.74% of its enlarged share capital. The HK$177.16 million subscription price will be fully settled by issuing new consideration shares in Aceso to IFGL under Aceso’s existing general mandate, structuring the deal as a share-for-share transaction that avoids the need for cash outlay. As the transaction size falls between 5% and 25% under Hong Kong Listing Rules, it is classified as a disclosable transaction, triggering reporting and announcement requirements but not shareholders’ approval, thereby allowing Aceso to move swiftly to deepen its strategic investment exposure while adhering to regulatory obligations.
The most recent analyst rating on (HK:0474) stock is a Hold with a HK$0.12 price target. To see the full list of analyst forecasts on Aceso Life Science Group Limited stock, see the HK:0474 Stock Forecast page.
More about Aceso Life Science Group Limited
Aceso Life Science Group Limited is a Hong Kong-listed company engaged in life science-related businesses, with its shares traded on the Main Board of the Stock Exchange of Hong Kong under stock code 00474. The group operates within the broader healthcare and life sciences sector, pursuing strategic investments and transactions to expand its portfolio and enhance shareholder value.
Average Trading Volume: 12,310,035
Technical Sentiment Signal: Buy
Current Market Cap: HK$885.8M
See more insights into 0474 stock on TipRanks’ Stock Analysis page.